Special Treatment. In exceptional circumstances, NSF may approve use of a special award provision to restrict or eliminate an awardee’s control of income earned through NSF-supported activities if it determines that this would best serve the purposes of a particular program or award. The special provisions may require treatment of the program income via use of the deductive method, the Federal share of program income be kept in a separate account, or reported on and/or remitted for such periods as may be reasonable under the circumstances. If, in accordance with the award terms and conditions program income is designated for deductive treatment, it must be remitted to NSF by crediting costs otherwise chargeable against the award. Program Income in excess of the award will be remitted to NSF electronically or by check payable to the National Science Foundation.
Special Treatment. Give each trademark “special treatment” so as to differentiate it from all other words. This is of particular importance in advertising, and it can be done in various ways. For example: (a) where the entire sentence (or leader) appears in block capital letters, enclose the trademark in quotation marks, underline it, display it in larger size letters than the other words or in a more prominent style or color, or use several of these techniques; or (b) display the trademark in block capital letters, but display all other words in the sentence in lower case letters. Remember that your objective is to emphasize the trademark. Of course, the common descriptive name of the product should not receive the same special treatment given to the trademark. The background behind a trademark should be suitably constant and contrasting and must not interfere with, or detract from, the instant recognition of the trademark. Textured and multicolored backgrounds should be avoided.
Special Treatment. In exceptional circumstances, NSF may approve use of a special grant provision to restrict or eliminate a grantee’s control of income earned through NSF-supported activities if it determines that this would best serve the purposes of a particular program or grant. The special provisions may require treatment of the program income via use of the deductive method, the Federal share of program income be kept in a separate account, or reported on and/or remitted for such periods as may be reasonable under the circumstances. If, in accordance with the grant terms and conditions program income is designated for deductive treatment, it must be remitted to NSF by crediting costs otherwise chargeable against the grant. Program Income in excess of the grant will be remitted to NSF electronically or by check payable to the National Science Foundation.
Special Treatment. The new regional grouping established due to the EPA scheme causes the problem of how to reconcile this approach with the previous special treatment of the group of least developed countries (LDCs) among the ACP countries. Currently, 40 of the 79 ACP countries are defined as LDCs by the United Nations. The LDCs constitute a special group among the developing countries and have usually been treated separately.
Special Treatment. Establish a personal relation with a specific consultant so that at least we can try again later) Tell successful testimonies Ask to take a break and see how that effects. Customer should know about wrong way of taking Eleotin®. No accusation. Do not ever try to make them believe that we are trying to prove them foolish. Point is not defense. But, understanding and consolation. We never promised a 100% cure. No such things exist. But, we want 100% satisfaction. The most frequent case: Not so serious initial state. They were made to believe that they have diseases. If the problem with the customers is not resolved by now, do not be afraid to say that you do not know the solution. Phrase it in such a way that does not patronize the customer and express your own disappointment. Issue D‐2: Responding to a customer who reports that they are cured POINTS:
Special Treatment. 10.8.1 Where deemed necessary by RRL after consultation with the depositor after assay determination by the XRF technique, deposits may be subjected to special treatment prior to further sampling or rejected in terms of clause 12. Product containing deleterious elements and/or compounds in excess of the amounts specified in this clause 10.8.1 will require resmelting and resampling for which additional charges, as set out in Annexure C, will be levied. The aforegoing will be necessary if the product contains more than 2% iron and/or more than 10% copper and/or more than 0,01 % platinum group metals (being platinum, palladium, osmium and/or iridium). Product containing more than 0,2% mercury and/or antimony will not be accepted for refining.
Special Treatment. No public official or employee shall grant any special consideration, treatment or advantage to any citizen beyond that which is available to every other citizen.
